Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model.

[1]  Tom Stanley,et al.  Instrumentation-Related Complications of Multilevel Fusions for Adult Spinal Deformity Patients Over Age 65: Surgical Considerations and Treatment Options in Patients With Poor Bone Quality , 2006, Spine.

[2]  A. Mofidi,et al.  Is High Level of Disability an Indication for Spinal Fusion?: Analysis of Long-Term Outcome After Posterior Lumbar Interbody Fusion Using Carbon Fiber Cages , 2005, Journal of spinal disorders & techniques.

[3]  Safdar N. Khan,et al.  Alendronate Inhibits Spine Fusion in a Rat Model , 2005, Spine.

[4]  G. Chatellier,et al.  Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism , 2005, BMJ : British Medical Journal.

[5]  Kozo Nakamura,et al.  Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. , 2005, Endocrinology.

[6]  M. Bouxsein,et al.  Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. , 2005, Endocrinology.

[7]  B. Mitlak,et al.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.

[8]  S. Komatsubara,et al.  Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.

[9]  K. Hing.  Bone repair in the twenty–first century: biology, chemistry or engineering? , 2004, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[10]  N. Lane,et al.  Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). , 2004, The Journal of clinical endocrinology and metabolism.

[11]  P. Aspenberg,et al.  Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  L. Qin,et al.  Parathyroid hormone: a double-edged sword for bone metabolism , 2004, Trends in Endocrinology & Metabolism.

[13]  J. F. Whitfield,et al.  Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase , 2004, Calcified Tissue International.

[14]  S. Ondra,et al.  Revision strategies for lumbar pseudarthrosis. , 2003, Neurosurgical focus.

[15]  B. L. Riggs,et al.  Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone , 2003, Journal of cellular biochemistry.

[16]  A. F. Stewart,et al.  Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  Munish C. Gupta,et al.  The Effects of BMP-7 in a Rat Posterolateral Intertransverse Process Fusion Model , 2003, Journal of spinal disorders & techniques.

[18]  T. Einhorn,et al.  Mechanisms for the Enhancement of Fracture Healing in Rats Treated With Intermittent Low‐Dose Human Parathyroid Hormone (1–34) , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  M. Ito,et al.  Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters. , 2002, Bone.

[20]  S. Boden,et al.  Overview of the Biology of Lumbar Spine Fusion and Principles for Selecting a Bone Graft Substitute , 2002, Spine.

[21]  A. Vaccaro,et al.  Bone grafting alternatives in spinal surgery. , 2002, The spine journal : official journal of the North American Spine Society.

[22]  J. Vahle,et al.  Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety , 2002, Toxicologic pathology.

[23]  R Müller,et al.  Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study * , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  S. Mohan,et al.  Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. , 2001, Endocrinology.

[25]  T A Einhorn,et al.  Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[27]  R. Lindsay,et al.  Parathyroid Hormone Added to Established Hormone Therapy: Effects on Vertebral Fracture and Maintenance of Bone Mass After Parathyroid Hormone Withdrawal , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  P. Aspenberg,et al.  Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats , 2000, Acta orthopaedica Scandinavica.

[29]  T A Einhorn,et al.  Parathyroid hormone enhances fracture healing. A preliminary report. , 1999, Clinical orthopaedics and related research.

[30]  P. Rüegsegger,et al.  The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. , 1999, Bone.

[31]  H. Oxlund,et al.  Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  L. Titus,et al.  1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.

[33]  J. Kinney,et al.  The Relationship Between Three‐Dimensional Connectivity and the Elastic Properties of Trabecular Bone , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  R. Lindsay,et al.  Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis , 1997, The Lancet.

[35]  T. J. Cypher,et al.  Biological principles of bone graft healing. , 1996, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[36]  W C Hutton,et al.  An Experimental Lumbar Intertransverse Process Spinal Fusion Model: Radiographic, Histologic, and Biomechanical Healing Characteristics , 1995, Spine.

[37]  A. Klibanski,et al.  Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. , 1994, The New England journal of medicine.

[38]  S. Boden,et al.  Spine update. The use of animal models to study spinal fusion. , 1994, Spine.

[39]  T. Whitecloud,et al.  Operative treatment of the degenerated segment adjacent to a lumbar fusion. , 1994, Spine.

[40]  L. Lenke,et al.  The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis. , 1993, Journal of spinal disorders.

[41]  R. Lindsay,et al.  Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.

[42]  R. Mcguire,et al.  The Use of Primary Internal Fixation in Spondylolisthesis , 1993, Spine.

[43]  T. Zdeblick.  A prospective, randomized study of lumbar fusion. Preliminary results. , 1993, Spine.

[44]  J. Hock,et al.  Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  D. Bradford,et al.  Results of spinal arthrodesis with pedicle screw-plate fixation. , 1991, The Journal of bone and joint surgery. American volume.

[46]  P. Rüegsegger,et al.  The ability of 3-D structural indices to reflect mechanical aspects of trabecular bone , 1999 .

[47]  R. L. Cain,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation , 2022 .